Combination therapy for overactive bladder in women
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares the effectiveness of a combination of medications (solifenacin and mirabegron) versus solifenacin alone with a vaginal estrogen cream for treating women with overactive bladder. It may help those who haven't improved with single medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with overactive bladder, specifically having involuntary bladder contractions.
- You have not improved enough with only one type of medication (antimuscarinics).
- You do not have trouble emptying your bladder completely after urination.
- You do not have medical conditions like narrow-angle glaucoma or uncontrolled high blood pressure that prevent use of the trial drugs.
- You have no history of conditions that prevent using estrogen, such as breast cancer, blood clots, or gallbladder disease.
- You have not used hormone replacement therapy in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding estrogen therapy to a combination of two bladder medications works better than the medications alone for women with overactive bladder that hasn't improved with standard treatment.
This study tests whether Botox injections work better than a combination of medicines (anti-muscarinics plus a beta-3 medicine) for people whose overactive bladder symptoms did not improve with one medicine alone. It may help by improving bladder control and reducing urgent, hard-to-hold urine leaks or frequent urination.
This study tests whether taking certain bladder medications at night can help reduce nighttime urination and improve sexual function, blood flow, and bladder health in women with overactive bladder. It compares four different drugs to see which works best for nighttime symptoms.
This study compares two non-invasive treatments for overactive bladder (sudden, frequent urges to pee) in women who haven't gotten relief from standard medications. One treatment uses a vaginal probe, the other uses pads on the perineum (area between the vagina and anus). Both aim to calm the bladder muscles.
This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.
This study tests whether combining two medications (gabapentin and solifenacin) works better for women with overactive bladder who have urgency and leakage. It may offer a new option if standard treatments haven't helped enough.
Hear when a new Urinary Bladder, Overactive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.